BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3733859)

  • 21. Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen.
    Woliński K; Kaznowski J; Klimowicz A; Maciejewski A; Łapińska-Cwojdzińska D; Gurgul E; Car AD; Fichna M; Gut P; Gryczyńska M; Ruchała M
    Endokrynol Pol; 2017; 68(4):434-437. PubMed ID: 28585679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcitonin, carcinoembryonic antigen and neuron-specific enolase in medullary thyroid carcinoma.
    Lloyd RV; Sisson JC; Marangos PJ
    Cancer; 1983 Jun; 51(12):2234-9. PubMed ID: 6342746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medullary thyroid cancer. An immunohistochemical and humoral study using six separate antigens.
    Pacini F; Basolo F; Elisei R; Fugazzola L; Cola A; Pinchera A
    Am J Clin Pathol; 1991 Mar; 95(3):300-8. PubMed ID: 1996540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of calcitonin and thyroglobulin gene expression in human mixed follicular and medullary thyroid carcinoma.
    Noel M; Delehaye MC; Segond N; Lasmoles F; Caillou B; Gardet P; Fragu P; Moukhtar MS
    Thyroid; 1991; 1(3):249-56. PubMed ID: 1824340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma.
    Bockhorn M; Frilling A; Rewerk S; Liedke M; Dirsch O; Schmid KW; Broelsch CE
    Thyroid; 2004 Jun; 14(6):468-70. PubMed ID: 15242577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcitonin and carcinoembryonic antigen in poorly differentiated follicular carcinoma.
    Calmettes C; Caillou B; Moukhtar MS; Milhaud G; Gerard-Marchant R
    Cancer; 1982 Jun; 49(11):2342-8. PubMed ID: 7042069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcitonin-like polypeptides without apparent biological activity in a patient with recurrent medullary thyroid carcinoma.
    Nakajima K; Jinkawa I; Hirota T; Ikeda T; Tugawa M; Minami Y; Hanada M
    Intern Med; 1995 Sep; 34(9):896-900. PubMed ID: 8580565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxyphil and squamous variants of medullary thyroid carcinoma.
    Dominguez-Malagon H; Delgado-Chavez R; Torres-Najera M; Gould E; Albores-Saavedra J
    Cancer; 1989 Mar; 63(6):1183-8. PubMed ID: 2917321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carcinoembryonic antigen in medullary thyroid carcinoma: an immunohistochemical study applying six novel monoclonal antibodies.
    Dasović-Knezević M; Børmer O; Holm R; Høie J; Sobrinho-Simões M; Nesland JM
    Mod Pathol; 1989 Nov; 2(6):610-7. PubMed ID: 2587568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment and characterization of continuous cell line MTC-SK derived from a human medullary thyroid carcinoma.
    Pfragner R; Höfler H; Behmel A; Ingolic E; Walser V
    Cancer Res; 1990 Jul; 50(13):4160-6. PubMed ID: 1972348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concurrent production of calcitonin and thyroglobulin by the same neoplastic cells.
    Holm R; Sobrinho-Simões M; Nesland JM; Johannessen JV
    Ultrastruct Pathol; 1986; 10(3):241-8. PubMed ID: 3715999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow-up of medullary thyroid carcinoma.
    Busnardo B; Girelli ME; Simioni N; Nacamulli D; Busetto E
    Cancer; 1984 Jan; 53(2):278-85. PubMed ID: 6690009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electron and immunoelectron microscopic study of thyroidal medullary carcinoma.
    Huang SN; Goltzman D
    Cancer; 1978 Jun; 41(6):2226-35. PubMed ID: 657088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early changes in carcinoembryonic antigen but not in calcitonin levels are correlated with the progression-free survival in medullary thyroid carcinoma patients treated with cytotoxic chemotherapy.
    Hajje G; Borget I; Leboulleux S; Chougnet C; Al Ghuzlan A; Mirghani H; Caramella C; Hartl D; Schlumberger M; Baudin E
    Eur J Endocrinol; 2013 Feb; 168(2):113-8. PubMed ID: 23093698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melanin production in a medullary thyroid carcinoma.
    Marcus JN; Dise CA; LiVolsi VA
    Cancer; 1982 Jun; 49(12):2518-26. PubMed ID: 6122498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electron microscopic demonstration of calcitonin in human medullary carcinoma of thyroid by the immuno gold staining method.
    Dämmrich J; Ormanns W; Schäffer R
    Histochemistry; 1984; 81(4):369-72. PubMed ID: 6511490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mixed medullary-follicular carcinoma of the thyroid. Immunohistochemical and electron microscopic studies.
    Ogawa H; Kino I; Arai T
    Acta Pathol Jpn; 1989 Jan; 39(1):67-72. PubMed ID: 2711836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrastructure, biological study and culture of C-cell carcinoma of the thyroid gland.
    Argemi B; Sudan N; Fayet G; Codaccioni JL
    Biomedicine; 1976 Nov; 24(5):352-8. PubMed ID: 1000020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ectopic secretion of calcitonin by lung and breast carcinomas.
    Coombes RC; Ellison ML; Easty GC; Hillyard CJ; James R; Galante L; Girgis S; Heywood L; MacIntyre I; Neville AM
    Clin Endocrinol (Oxf); 1976; 5 Suppl():387S-396S. PubMed ID: 1053252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medullary carcinoma of the thyroid: a cytological, immunocytochemical, and ultrastructural study.
    Bose S; Kapila K; Verma K
    Diagn Cytopathol; 1992; 8(1):28-32. PubMed ID: 1551364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.